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Store-operated Ca2þ entry (SOCE) is an important mechanism of extracellular Ca2þ entry into cells. It has
been proved that SOCE is involved in many pathologic and physiological processes. Two key participants
of SOCE, stromal interaction molecule1 (STIM1) and Orai1, have been identiﬁed. But their function in
cardiac ﬁbroblasts remains elusive. In present study, our ﬁndings suggested the expression of STIM1 and
Orai1 were increased followed by angiotensin II (Ang II) stimulation in vivo and in vitro. In cultured adult
rat cardiac ﬁbroblasts, Ang II led to STIM1 interact with Orai1 and Ca2þ release from intracellular calcium
store. In addition, the upregulation of ﬁbronectin (FN), connective tissue growth factor (CTGF) and
smooth muscle a-actin (a-SMA) induced by Ang II were attenuated by SOCE inhibitor SKF-96365, similar
results were observed by knocking down STIM1 and Orai1. Furthermore, we found that silencing Orai1
by RNA interference also suppressed the translocation of Nuclear Factor of Activated T-cells (NFAT)
Isoforms NFATc4 and decreased the phosphorylation of Smad2 and Smad3 induced by Ang II. These
results unraveled a novel role of SOCE as a key modulator in the Ang II-induced cardiac ﬁbrosis by
mediating Ca2þ inﬂux.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Cardiac ﬁbrosis is characterized by an accumulation of excessive
extracellular matrix (ECM) proteins produced by cardiac ﬁbroblasts
and its differentiated phenotype, myoﬁbroblasts (1). Under physi-
ological conditions, cardiac ﬁbroblasts (CFs) are involved in main-
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d/4.0/).pathologic stimuli such as myocardial injury, oxidative stress, me-
chanical stretch and proﬁbrotic cytokines, CFs would proliferate,
migrate and differentiate to myoﬁbroblasts, culminating in cardiac
ﬁbrosis (1e3). Cardiac ﬁbrosis is a detrimental factor leading to
hypertrophic scar, loss of tissue compliance and distorted archi-
tecture and function of heart (4). Therefore, inhibiting cardiac
ﬁbrosis especially the accumulation of ECM is a vital process to
reduce pathological cardiac remodeling.
As a pivotal component of renineangiotensin system, Ang II
plays a critical role in cardiac diseases. It promotes cardiac myocyte
hypertrophy and cardiac ﬁbroblast ﬁbrotic changes (5,6). These
pro-ﬁbrotic effects of Ang II in the heart are multiple (6). In
particular, a large body of evidence supports that Ang II triggers
ﬁbrogenesis cascade via Ca2þ signaling (7,8).
Ca2þ signaling is essential for physical or pathological processes
in variety of tissues and organs. Store-operated Ca2þ entry (SOCE) is
a ubiquitous mechanism for Ca2þ inﬂux in mammalian cells, it is
controlled by the ﬁlling state of the intracellular Ca2þ stores (9). Thenese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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comprising the critical ER-located Ca2þ sensor and the highly Ca2þ
selective pore-forming subunit of the Ca2þ release-activated Ca2þ
channel (CRAC), respectively (10). At resting state, STIM1 exhibits a
tubular distributionwithin endoplasmic reticulum (ER) membrane.
When ER Ca2þ store is depleted by inositol 1,4,5-triphosphate (IP3)-
induced Ca2þ release, Ca2þ is dissociated from the EF-hand motifs
of STIM1, which further causes STIM1 to oligomerize and relocate at
ER/PM junctions where STIM1 binds to Orai1, culminating in
channel opening (11, 12). The actions of Ang II are mediated mostly
by binding to AT1R and AT2R, which are important G-protein
coupled receptors (GPCRs). AT1R activation can activate a series of
cell signaling pathways, and cause the phosphorylation of phos-
pholipase C-g1 which cleaves phosphatidylinositol 4,5-
bisphosphate (PIP2) to produce IP3 and diacylglycerol (DAG) (13,14).
However, it is still unknown whether Ang II can activate the
SOCE signaling pathway in CFs and what is the potential role in
cardiac ﬁbrosis. In present research, we conﬁrmed the expression of
STIM1 and Orai1 in CFs, and further identiﬁed that Ang II could
activate SOCE, whichmediated the overexpression of ECM proteins,
differentiation of cardiac ﬁbroblasts and rise of ﬁbrogenic cytokines
through calcium signal.
2. Materials and methods
2.1. Materials
Dulbecco's modiﬁed Eagle's medium (DMEM), fetal bovinese-
rum (FBS), collagenase type II, penicillin/streptomycin, ﬂuo-4/AM
were all purchased from Invitrogen/GIBCO (Grand Island, NY,
USA). SKF96365 and anti-CTGF, anti-NFATc4, anti-FN antibodies
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Trypsin, Anti-Orai1 and anti-a-SMA antibodies were obtained
from SigmaeAldrich (St. Louis, MO, USA). Anti-STIM1, Anti-Phos-
pho-Smad2, anti-Phospho-Smad3, anti-TGFb1 and anti-Lamin B1
antibodies were purchased from Cell Signaling Technology (Dan-
vers, MA, USA). Anti-Col I antibody was purchased from Proteintech
Group Inc (Chicago, IL, USA). Ang II was purchased from Merck
Millipore (Billerica, MA, USA). Other chemicals and reagents were
all from SigmaeAldrich unless otherwise indicated.
2.2. Primary cardiac ﬁbroblasts culture
The experimental protocol for the handling of animals complied
with the Guidelines of Animal Experiments from Ethical Committee
for Animal Research of Sun Yat-sen University.
Primary adult rat cardiac ﬁbroblasts were prepared as described
previously (7). Brieﬂy, cardiac ventricles from adult male Spra-
gueeDawley rats (Experimental Animal Center of Sun Yat-Sen
University, Guangzhou, China) (180e220 g) were separated and
cut into 1-mm3 volume pieces. Then these small pieces were
digested in 0.1% collagenase type II for 30 min at 37 C, followed by
0.25% trypsin for three 5-min periods. After that, repeat collagenase
type II digestion steps 2e3 times until the tissues were completely
digested. Then cells were combined, centrifuged, and resuspended
in DMEM containing 10% fetal bovine serum. After 1 h incubation,
the non-adhered cells were removed and the attachedwere further
cultured in a humidiﬁed atmosphere of 5% CO2 at 37 C. Cells from
passages 2e4 were used for experiments.
2.3. Animal models
C57BL/6 mice (male, weighing 20e25 g, SPF grade) were sup-
plied by the Experimental Animal Center of Sun Yat-Sen University
(Guangzhou, China). The investigation conformed to the Guide forthe Care and Use of Laboratory Animals published by the US Na-
tional Institutes of Health.
The animal experiments were performed as described (15).
Brieﬂy, mice were randomly divided into vehicle control group and
Ang II-infused group. Mice in control group were infused with
normal saline and those inAng II-infused groupwere receivedAng II
(1.2 mg/kg/day) by an implanted subcutaneous minipump (ALZET
micro-osmotic pump MODEL 1002 DURECT Co., Cupertino, CA) for
two weeks.
2.4. Cytotoxicity assay
CFs were seeded on 96-well plates (5  104 cells/mL) and
treated with different concentration (2.5e20 mM) of SKF96365
(Sigma, 98% purity) for 24 h. Before the ending, cells were incu-
bated with 3-(4,5-dimethylthiazol-2-y1)-2,5-dipheny- lte-
trazolium bromide (MTT, SigmaeAldrich, St. Louis, MO, USA) in the
ﬁnal concentration of 0.5 mg/mL for 4 h at 37 C. The medium was
then replaced with 100 ml dimethyl sulfoxide and agitated for
10 min. The optical density at 490 nm was measured with an
automated micro-plate reader (Bio-Tek, Winooski, VT, USA).
2.5. Western blot analysis
Total protein from cultured cells or mice heart tissues were
extracted as described previously (7). Brieﬂy, after different treat-
ments, proteins were collected in RIPA lysis buffer (Beyotime
Biotechnology, Shanghai, China) on ice with protease inhibitor
PMSF. Total protein content was determined by using BCA Protein
Assay Kit (Thermo Scientiﬁc, Waltham, MA, USA). Samples of
whole-cell lysates or tissue lysates were separated by 8% sodium
dodecyl sulfateepolyacrylamide gel electrophoresis and then
transferred onto polyvinylidene diﬂuoride (PVDF) membranes
(Millipore, Billerica, MA, USA). The membranes were blocked in
Tris-buffered salineeTween 20 (TBST) with 5% (wt/vol) skimmed
milk for 1.5 h at room temperature and then were incubated with
primary antibodies at 4 C overnight. The antibodies used are as
follows: FN (220 kDa, 1:1000 dilution), CTGF (37 kDa, 1:2500
dilution), a-SMA (42 kDa, 1:1000 dilution), STIM1 (90 kDa, 1:2500
dilution), Orai1 (30e50 kDa, 1:2000 dilution), Col I (130 kD, 1:1000
dilution) Phospho-Smad2 (60 kDa, 1:1000 dilution), a-Tubulin
(55 kDa, 1:10,000 dilution). The membranes were washed 3 times
with TBS-T and then incubated with corresponding horseradish
peroxidases (HRP)-labeled secondary antibodies (1:10,000 dilution,
Cell Signaling Technology) for 1 h at room temperature. Immuno-
reactive bands were visualized with Super Signal West Pico
Chemiluminescent Substrate (Pierce). The relative intensities of
protein bands were analyzed by Quantity-One software (Bio-Rad,
Hercules, CA, USA) and a-Tubulin was used as the loading control.
To detect NFATc4 translocation, nuclear proteinwere extracted by
using a commercial available Nuclear and Cytoplasm Extract kit
(Active Motif, USA) according to the manufacturer's recommenda-
tions,Western blottingwas performed as previously described. Anti-
NFATc4 (140 kDa) antibodywas diluted at 1:1000, Lamin B1 (70 kDa,
1:2500 dilution) was used as the loading control of nucleoprotein.
2.6. Co-immunoprecipitation
Cardiac ﬁbroblasts with different treatments were washed in
phosphate buffered saline (PBS) and lysed in 1%NP-40 lysis buffer
containing protease inhibitors, 0.1 mMPMSF,1 mg/ml aprotinin, and
5 mg/ml leupeptin. The protein was collected and centrifuged at
14,000 g for 15 min. Protein concentration was determined and an
equal amount (200 mg) of each cell extract was incubated with 1 mg
of afﬁnity puriﬁed primary antibody or immunoglobulin G (IgG)
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agarose beads (Pierce, USA) for 4e6 h. The beads were washed with
different lysis buffer for three times and boiled in loading buffer for
5 min. Western blotting was performed as previously described.
Cell extract (200 mg) without immunoprecipitation was used as a
source of marker proteins (Input) and was submitted directly to
immunoblotting.
2.7. Immunoﬂuorescence staining
CFs plated on coverslips were ﬁxed with 4% formaldehyde for
30 min, permeabilized with 1% Triton X-100 for 10 min, then
blocked with 10% goat serum for 1 h at room temperature and
further incubated with mouse anti-a-SMA antibody overnight at
4 C. The cells were thenwashed for three times and incubatedwith
Alexa Fluor 488-labeled anti-mouse secondary antibody. The cells
were washed with PBS and were stained with Hoechst 33342 for
10 min. Zeiss LSM 710 confocal microscope was used to detect
immunostained cells. Images were captured in the same settings of
pinhole width, laser intensity and detector gain.
2.8. Fluorescence imaging of intracellular Ca2þ
Measurement of intracellular Ca2þ level was performed as
previously described (16). CFs plated on coverslips were washed
with standard Tyrode solution (in mmol/L: 145 NaCl, 4 KCl, 10
glucose, 1 MgCl2, 1.8 CaCl2, and 10 HEPES [pH 7.4]) and loaded with
5 mM Ca2þ sensitive dye ﬂuo-4/AM at 37 C for 30 min. After that,Fig. 1. Ang II induced the upregulation of STIM1 and Orai1 in vivo and in vitro. (A and B)
Mice in control group were infused with normal saline (NS). Western blot analysis of protein
panel is the summary data from three independent experiments. All values were expresse
100 nM of Ang II for indicated time. The protein levels of STIM1 and Orai1 were detected aCells were washed with Tyrode solution for three times. Cells on a
single coverslip were monitored using Laser Scanning Confocal
Microscope (Zeiss LSM710). Fluorescence values at excitation and
emission wavelengths of 488 nm and 516 nm, respectively, were
measured consecutively. Normalized intracellular Ca2þ changes
were reported as the background-corrected ﬂuorescence emission
ratio F/F0, F was real time ﬂuorescence intensity and F0 was the
steady-state condition ﬂuorescence value.
2.9. Gene silencing of STIM1 and Orai1 in cardiac ﬁbroblasts
Duplex small interfering RNAs (siRNAs) for rat STIM1, Orai1 and
negative control siRNA were purchased from Genepharma
(Shanghai, PR China). siRNA for rat STIM1: sense 50-GCCAUAGU-
CACAGUGAGAATT-30, antisense 50-UUCUCACUGUGACUAUGGCTT-
30, siRNA for rat Orai1: sense 50-CCUGGUGUUUAUCGUCUUUTT-30,
antisense 50-AAAGACGAUAAACACCAGGTT-30. Cardiac ﬁbroblasts
were transiently transfected with 100 nM of the indicated siRNA
using 5 ml of the transfection reagent Lipofectamine 2000 (Invi-
trogen, Life Technologies, Carlsbad, California, USA). For a negative
control, cells were transfected with a control siRNA duplex.
Silencing efﬁciency of different duplex siRNAs and the corre-
sponding molecular effects were detected by western blot.
2.10. Statistical analysis
Data are presented as mean ± SEM. Statistical analysis was
performed with the use of GraphPad Prism Software, Version 5.02C57 mice in Ang II-infused group were infused with Ang II (1.2 mg/kg/day) for 2 weeks,
levels of FN, STIM1, Orai1. Left panels are representative images of Western blot. Right
d in relation to that of control. *P < 0.05 vs. control. (C and D) CFs were treated with
nd normalized by a-tubulin. *P < 0.05 vs. control.
Fig. 2. Ang II induced the interaction of STIM1 and Orai1. (A) Total protein of control
or Ang II treated cardiac ﬁbroblasts was immunoprecipitated with anti-Orai1 anti-
bodies, and then STIM1 was analyzed by immunoblotting. (B) Total protein of control
or Ang II treated cardiac ﬁbroblasts was immunoprecipitated with anti-STIM1 anti-
bodies, and then Orai1 was analyzed by immunoblotting. The panels are representative
images of three independent experiments.
Fig. 3. SKF96365 pretreatment effected Ang II-induced [Ca2þ]i changes in cardiac ﬁbrobl
solution. CFs were pre-incubated with/without 10 mM SKF96365 for 30 min before being stim
real time ﬂuorescence intensity of ﬂuo-4, and F0 was the ﬂuorescence intensity of ﬂuo-4 und
change of [Ca2þ]i under acute Ang II (100 nM, 5 min) stimulation. The arrow indicates the t
*P < 0.05 vs. control; #P < 0.05 vs. Ang II. (C) SKF96365 treatment (10 mM) obviously block
mean ± SEM from 10 cells. *P < 0.05 vs. Ang II.
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groups was tested by paired or unpaired Student's t-test. Statistical
analysis among the various groups was performed by One-way
analysis of variance (ANOVA) with Bonferroni post hoc test. In all
cases, difference between groups was considered statistically sig-
niﬁcant at P < 0.05. And the statistical data were from at least three
independent experiments.3. Results
3.1. STIM1 and Orai1 were increased by Ang II stimulation in CFs
and mice heart
To examine whether there were alterations of STIM1 and Orai1
protein levels in mice after being treated with Ang II (1.2 mg/kg/
day) for 2 weeks, total protein of left ventricular tissue was
extracted and detected by western blot. As shown in Fig. 1A and B,
FN was signiﬁcantly increased in Ang II-infused group, suggesting
the successful induction of cardiac ﬁbrosis by Ang II. In addition,
protein expression of STIM1 and Orai1 weremarkedly up-regulated
(P < 0.05). Besides, we also determined that Ang II (100 nM,
6e48 h) induced expression of STIM1 and Orai1 in CFs (Fig. 1C and
D). In order to investigatewhether Ang II could activate SOCE in CFs,
we examined the interaction of STIM1 and Orai1 under the stim-
ulation of Ang II by co-immunoprecipitation. The combinationasts. (A) SKF96365 reduced the elevation of [Ca2þ]i induced by Ang II in standard Tyrode
ulated with 100 nM Ang II. Changes of [Ca2þ]i was reported as the F/F0, where F was the
er steady conditions at the beginning of the experiment. SKF96365 decreased the rapid
ime adding Ang II. (B)The summary data were ﬂuorescence mean ± SEM from 10 cells.
ed Ang II-induced calcium release and SOCE. (D) The summary data were ﬂuorescence
Fig. 4. SKF96365 blocked Ang II-induced up-regulation of CTGF, a-SMA and FN in cardiac ﬁbroblasts. (A) The effect of different concentration of SKF96365 on cardiac ﬁbroblasts
viability was detected by MTT assay. (BeD) SKF96365 (10 mM) inhibited Ang II (100 nM, 24 h)-induced overexpression of CTGF, a-SMA and FN in CFs. The summary data were from
three independent experiments. *P < 0.05 vs. control; #P < 0.05 vs. Ang II.
Fig. 5. Down-regulation of Orai1 and STIM1 reduced SOCE in cardiac ﬁbroblasts. (A and C) Orai1 Si-RNA (A) (Top panel) and STIM1 Si-RNA (C) (Top panel) shortened the
sustained Ca2þ inﬂux plateau, but did not affect the transient increase peak under acute Ang II (100 nM, 5 min) stimulation. *P < 0.05 vs. NC þ Ang II. (B and D) Calcium change in
2 mM Ca2þ peak phase could be reduced in siRNA-Orai1 (B) (Top panel) and siRNA-STIM1 (D) (Top panel) cells and the same as negative control in 0 Ca2þ peak phase. Bottom panels
are the summary data shown by ﬂuorescence intensity with mean ± SEM from 10 cells. *P < 0.05 vs. NC þ Ang II.
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Ang II stimulation.3.2. SKF96365 attenuated Ang II-induced Ca2þ inﬂux
We further tested whether Ang II can induce Ca2þ inﬂux in CFs
by monitoring a change of ﬂuo-4 ﬂuorescence ratio F/F0. As shown
in Fig. 3A, intracellular Ca2þ was rapidly increased by acute Ang II
stimulation in standard Tyrode solution, followed by a plateau of
elevated [Ca2þ]i. The sustained plateau level is indicative of induced
Ca2þ inﬂux (17). Both the initial peak response and the sustained
plateau were signiﬁcantly attenuated by pretreatment with 10 mM
SKF96365, the inhibitor of SOCE. In addition, we also conﬁrmed
that SKF96365 inhibited Ang II-induced SOCE. SOCE in CFs was
analyzed using a standard Ca2þ add-back assay, In which cells were
incubated in Ca2þ-free Tyrode solution, Ca2þ stores were depleted
in the stimulation of Ang II, extracellular Ca2þwas then added back
to monitor Ca2þ inﬂux. As shown in Fig. 3C, there were two distinct
peak phases (black line). One was induced by Ang II. The other was
dependent on the restoration of 2 mM extracellular Ca2þ, which
was the process of SOCE. Both peak phases could be largelyFig. 6. Silencing Orai1 attenuated Ang II-induced overexpression of FN, CTGF and a-SM
24 h)-induced protein expressions of FN and CTGF. The values are represented as mean ± SE
increase of protein expressions of a-SMA induced by Ang II was inspected by confocal micinhibited by SKF96365 (red line). We also detected non-speciﬁc
inhibitor 2-aminoethoxydiphenylborate (2-APB) suppressed both
sustained increase in intracellular Ca2þ caused by AngII application
and Ca2þ entry induced by the addition of 2 mM Ca2þ
(Supplemental Fig. 1A and 1B).3.3. SKF96365 inhibited Ang II-induced CTGF, a-SMA and FN up-
regulation in CFs
The expression of CTGF indicates the activation of ﬁbroblasts,
which can further promote adhesion and the expression of ECM
(18). In normal ﬁbroblasts, the expression of a-SMA is scanty but
can be detected when it differentiate into myoﬁbroblasts (19).
Fibronectin is an important component of ECM proteins that is
essential for cell adhesion, growth (19,20). To investigate the effect
of SKF96365, the inhibitor of SOCE, on Ang II-induced ﬁbroblasts
activation, differentiation and ECM proteins accumulation, we
detected the protein levels of CTGF, a-SMA and FN. The effect of
various concentrations of SKF96365 on the cardiac ﬁbroblasts
viability was assessed using MTT assay. As shown in Fig. 4A,
SKF96365 (2.5e20 mM) had no signiﬁcant cytotoxic effect on CFs atA in cardiac ﬁbroblasts. (A and B) Orai1-SiRNA signiﬁcantly reduced Ang II (100 nM,
M from three separate experiments. *P < 0.05 vs. NC; #P < 0.05 vs. NC þ Ang II. (C) The
roscope.
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group, Ang II (100 nM) treatment for 24 h greatly promoted the
production of CTGF (Fig. 4B), a-SMA (Fig. 4C) and FN (Fig. 4D)
(P < 0.05 vs. control), which were signiﬁcantly suppressed by the
treatment of SKF96365 (10 mM) (P < 0.05 vs. Ang II).3.4. Knockdown of Orai1 or STIM1 reduced Ang II-induced Ca2þ
inﬂux
To test whether Orai1 and STIM1 were required for Ang II-
induced Ca2þ inﬂux, their expressions were knocked down by
siRNAs. Real-time PCR and Western blot were performed to eval-
uate the knockdown efﬁciency of siRNAs. Three independent Orai1
siRNAs marked si-1, si-2, and si-3, respectively. As shown in
Supplemental Fig. 2A and 2B, si-3 reduced the mRNA and protein
expressions of Orai1 by 74.2% and 75.5%, respectively (P < 0.05).
Therefore, si-3 targeting to Orai1 was used in the following ex-
periments. Three independent STIM1 siRNAs marked si-1, si-2, and
si-3, respectively. As shown in Supplemental Fig. 2C and 2D, si-1
transfection signiﬁcantly reduced the mRNA and protein expres-
sion of STIM1 by 73.6% and 77.4%, respectively (P < 0.05). Therefore,
si-1 targeting to STIM1 was selected for the following experiments.
Ang II induced a transient and then sustained increase of intracel-
lular Ca2þ in standard Tyrode solution. Orai1 siRNA and STIM1
siRNA did not affect the transient increase peak, but shortened the
sustained Ca2þ inﬂux plateau (Fig. 5A and C). Besides, Ang IIFig. 7. Silencing STIM1attenuatedAng II-inducedoverexpressionof Col I, FN,a-SMAandCT
induced protein expressions of Col I, FN, a-SMA and CTGF. The values are represented as meanstimulation evoked a transient ER Ca2þ release in Ca2þ-free Tyrode
solution, followed by the SOCE after the restoration of 2 mM
extracellular Ca2þ, Knockdown of Orai1 or STIM1 had no signiﬁcant
effect on calcium release but led to similar suppression of SOCE
(Fig. 5B and D).
3.5. Knockdown of Orai1 inhibited the ﬁbrogenic responses to Ang II
stimulation in CFs
To conﬁrm the role of SOCE in Ang II-induced cardiac ﬁbro-
genesis, we took the approach of RNA interference to knock down
the Ca2þ channel Orai1 in CFs. Compared to negative control group,
the upregulation of FN (Fig. 6A), CTGF (Fig. 6B), a-SMA
(Supplemental Fig. 3) induced by Ang II were signiﬁcantly attenu-
ated in Orai1-siRNA group (P < 0.05). Silencing Orai1 alone had no
signiﬁcant effects on the basal expression. Furthermore, immuno-
ﬂuorescent staining assay revealed Orai1 depletion reversed the
increase of a-SMA protein expression in CFs treated with Ang II
(Fig. 6C).
3.6. Knockdown of STIM1 attenuated Ang II-induced up-regulation
of ﬁbrogenic biomarkers FN, Col I, CTGF, a-SMA
To further verify the involvement of STIM1 in Ang II-induced
cardiac ﬁbrosis, we investigated the effect of silencing STIM1 on
the expression of Col I, FN, a-SMA and CTGF. Col I is considered asGF in cardiacﬁbroblasts. (AeD) STIM1-siRNA signiﬁcantly reducedAng II (100 nM, 24 h)-
± SEM from three separate experiments.*P < 0.05 vs. NC; #P < 0.05 vs. NC þ Ang II.
Fig. 8. Knockdown of Orai1 inhibited Ang II-induced translocation of NFATc4 and phosphorylation of Smad2 and Smad3. (A) Knockdown of Orai1 inhibited Ang II-induced
translocation of NFATc4. The nuclear protein levels of NFATc4 were detected and normalized by Lamin B1 and then presented as fold of negative control level. The summary data
were from three independent experiments.*P < 0.05 vs. NC; #P < 0.05 vs. NC þ Ang II. (B) Ang II induced TGF-b1 expression in a time-dependent manner in cardiac ﬁbroblasts.
*P < 0.05 vs. control. (C) Ang II induced phosphorylation of Smad2. CFs were treated with 100 nM Ang II for indicated time. Phosphorylation of Smad2 reached to the highest level at
24 h. The values are represented as mean ± SEM from three separate experiments. *P < 0.05 vs. control. (DeF) Orai1 siRNA transfection prevented Ang II-induced expression of TGF-
b1 and phosphorylation of Smad3 and Smad2. The values are represented as mean ± SEM from three separate experiments. *P < 0.05 vs. NC; #P < 0.05 vs. NC þ Ang II.
B. Zhang et al. / Journal of Pharmacological Sciences 132 (2016) 171e180178the important ECM protein, so we further chose it as one of the
biomarkers of cardiac ﬁbrosis. Protein expression of Col I, FN, a-
SMA and CTGF were signiﬁcantly increased after stimulation with
Ang II (100 nM) for 24 h (P < 0.05), whereas silencing STIM1 pro-
foundly prevented the upregulation (Fig. 7AeD) (P < 0.05).3.7. Knockdown of Orai1 inhibited Ang II-induced translocation of
NFATc4 and phosphorylation of Smad2 and Smad3
Ca2þ entry mechanism is necessary for NFAT nuclear localiza-
tion/activation and proper cytokine expression (21). Moreover,
B. Zhang et al. / Journal of Pharmacological Sciences 132 (2016) 171e180 179among the NFAT familymembers, NFATc4 has been reported to play
important roles in cardiac ﬁbrosis and are critical for heart devel-
opment (22). Herein, we investigated the effect of silencing Orai1
on the translocation of NFATc4. As shown in Fig. 8A, Ang II-induced
NFATc4 translocation was prevented by Orai1 siRNA transfection.
Evidence has shown that Ang II can activate Smad pathway, the
pivot signal pathway associated with ﬁbrosis, via a Transforming
Growth Factor-b (TGF-b)-dependent or independent mechanism
(23,24), sowe further detectedwhether SOCE contributed to Ang II-
activated Smad pathway. Results indicated that Ang II induced TGF-
b1 expression and Smad2 phosphorylation in cardiac ﬁbroblasts
(P < 0.05) (Fig. 8B and C). As shown in Fig. 8DeF, Orai1 siRNA
transfection prevented Ang II-induced TGF-b1 expression and the
phosphorylation of Smad3 and Smad2 (P < 0.05).4. Discussion
Extensive evidence has shown that Ca2þ, a universal intracel-
lular messenger, was involved in cardiac ﬁbrosis (25). Hence,
intervention andmodulation of Ca2þ channels might be an effective
way to prevent myocardial ﬁbrosis and various heart diseases.
Previous research revealed that classical blockers of L-type calcium
channels had no effect on the variation in intracellular Ca2þ con-
centration in cultured rat cardiac ﬁbroblasts (26), indicating that
some other channels may contribute to the increase of [Ca2þ]i in
cardiac ﬁbroblasts and resultant ﬁbrosis. Store-operated Ca2þ entry
constitutes one of the major routes of calcium entry in non-
excitable cell, and it is a process that the depletion of intracellular
Ca2þ stores causes the inﬂux of extracellular Ca2þ (27,28) The
identiﬁcation of STIM1 as the endoplasmic reticulum Ca2þ sensor
and Orai1 as a component of the Ca2þ release-activated Ca2þ
(CRAC) channel make the procedure of SOCE clear. Emerging evi-
dence suggests that SOCE is involved in the progression of cardio-
vascular diseases. Silencing Orai1 or Stim1 protein exerted a
profound inhibition of myocardial hypertrophy and completely
abrogated the phenylephrine-mediated increase in neonatal rat
cardiac myocytes size (29,30). Here, we conﬁrmed that SOCE was
activated by Ang II stimulation in CFs, which led to a ﬁbrotic
cascade.
In the ﬁrst set of experiments, we revealed that STIM1 and Orai1
were upregulated under Ang II stimulus in vivo and in vitro, which
might be associated with pathogenesis of various heart diseases.
STIM1 and Orai1 are both mobile proteins that are relatively
diffusely localized throughout the ER and plasma membranes,
respectively. Upon store depletion, STIM1 accumulates and binds to
Orai1, leading to the opening of CRAC channel (31e33). Our re-
searches indicated that the combination of STIM1 and Orai1 was
increased by Ang II stimulation. It appears that Ang II may induce
the activation of SOCE in CFs.
We further found that SKF96365, an inhibitor of SOCE, could
dramatically attenuate the occurrence of SOCE induced by Ang II.
Moreover, our ﬁndings suggested that SKF96365 greatly inhibited
Ang II-induced accumulation of ECM. These ﬁndings indicated that
SOCE played a crucial role in Ang II-induced myocardial
ﬁbrogenesis.
Further conﬁrmation for the involvement of SOCE in the Ang II-
induced myocardial ﬁbrogenesis was sought using a gene silencing
technique. We found that silencing Orai1 or STIM1 substantially
attenuated SOCE activation in CFs due to ER/SR Ca2þ depletion, but
not affected Ca2þ release from Ca2þ Store. This suggested that Stim1
and Orai1 were required for SOCE in CFs. Importantly, decreasing
either Orai1 or Stim1 protein alone was sufﬁcient to exert a pro-
found anti-ﬁbrotic effect, pointing to the requirement of both
STIM1 and Orai1 in Ang II-induced ﬁbrogenic response.Given the fact that Ang II could stimulate the activation of SOCE
and induce cardiac ﬁbrosis, it was tempting to speculate that Ca2þ
entry led to the activation of Ca2þ dependent growth via calcium-
related signaling pathway and contributed to pathological
ﬁbrosis. In light of previous researches, nuclear factor of activated T-
cells (NFAT) pathway, a critical Ca2þ-responsive signaling path-
ways, is involved in the process of ﬁbrogenesis (22,34). Besides, it is
also revealed that activation of SOCE is sufﬁcient to trigger calci-
neurin/NFAT signaling (35). Our data suggested that the trans-
location of NFATc4 was increased after Ang II stimulation in CFs,
which could be inhibited by knockdown of Orai1. This result
conﬁrmed that Ang II can activate NFAT signaling by inducing SOCE
in CFs. TGF-b/Smad pathway is also an important signal pathway
associated with ﬁbrosis. Ang II treatment signiﬁcantly up-regulated
mRNAs for TGF-b1, and increased the phosphorylation of TGF-b
downstream signaling markers (24). Recent research stated that
Ca2þ inﬂux activates Smad2/3 dependent TGF-b signaling in facil-
itating up-regulated expression of a-SMA and collagen (36). Our
ﬁndings indicated that treatment with Ang II activated TGF-b/Smad
pathway, which were alleviated by silencing Orai1. We speculate
that Ang II stimulation induced the continuous Ca2þ inﬂux through
SOC, followed by the elevation of cytosolic Ca2þ concentration. The
increased [Ca2þ]i was sufﬁcient to activate Ca2þ sensitive signaling
or crosstalk with other signal to initiate TGF/smad pathway,
culminating in cardiac ﬁbrosis. It raises the possibility that the SOCE
may be the initial/initialize signal in cardiac ﬁbrosis andmyocardial
remodeling.
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